McGill MBAs place first in North America on international mobility according to Financial Times global survey
The Financial Times of London survey of 100 MBA programs in the world, released on January 24, 2005, places McGill graduates first in North America – and 11th worldwide – for international mobility. This measure is based on the employment movements of alumni between time of graduation and today. The FT results are based on a survey of the 2001 alumni and an analysis of each school's activities.
"Yalla: Reflections on the Middle East," co-sponsored by the McGill Arab Students' Association and Hillel Jewish Student Centre of McGill, compiles poems, stories, essays and photos on the theme of hope for an end to the Israeli-Palestinian conflict.
For patients with high-risk breast cancer treated with radical mastectomy and adjuvant chemotherapy, the addition of radiation therapy leads to better survival outcomes with few long-term toxic effects.
The first baby born at the McGill University Health Centre for 2005 was a baby boy, at 00:02 am on January 1, 2005.
The McGill MBA - Opening Doors Around the World. Information session on Tuesday, February 8, 2005.
The Ministry of Health and Social Services has released preliminary findings from its provincial surveillance on the incidence of Clostridium difficile in Quebec.
Out of ten McGill faculty members, three Management professors were included in the Reporter's list of McGill's top 2004 newsmakers.
The McGill pass rate for the Chartered Accountancy UFE exam from 2001-2004 for first-time writers averaged 85%, and 100% for second-time writers. These are the highest pass rates McGill has posted in its history, with 97% of McGill graduates from this period obtaining their CA designation.
"Hardwood," a 29-minute film written and directed by Hubert Davis (BA'00), has earned a nomination in the Academy Awards short documentary category. Davis's father is former Harlem Globetrotter Mel Davis. The younger Davis uses interviews and home movies to explore his father's relationship with his family.
New research published in the online version of the Annals of Internal Medicine today documents an increased risk of heart attack with one of the COX-2 inhibitors used in elderly adults with no previous history of heart attack.